1. Home
  2. MRUS vs BRZE Comparison

MRUS vs BRZE Comparison

Compare MRUS & BRZE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRUS
  • BRZE
  • Stock Information
  • Founded
  • MRUS 2003
  • BRZE 2011
  • Country
  • MRUS Netherlands
  • BRZE United States
  • Employees
  • MRUS 260
  • BRZE N/A
  • Industry
  • MRUS Biotechnology: Pharmaceutical Preparations
  • BRZE Computer Software: Prepackaged Software
  • Sector
  • MRUS Health Care
  • BRZE Technology
  • Exchange
  • MRUS Nasdaq
  • BRZE Nasdaq
  • Market Cap
  • MRUS 4.1B
  • BRZE 3.9B
  • IPO Year
  • MRUS 2016
  • BRZE 2021
  • Fundamental
  • Price
  • MRUS $53.11
  • BRZE $25.84
  • Analyst Decision
  • MRUS Strong Buy
  • BRZE Strong Buy
  • Analyst Count
  • MRUS 12
  • BRZE 20
  • Target Price
  • MRUS $87.92
  • BRZE $46.60
  • AVG Volume (30 Days)
  • MRUS 2.0M
  • BRZE 1.9M
  • Earning Date
  • MRUS 07-31-2025
  • BRZE 06-05-2025
  • Dividend Yield
  • MRUS N/A
  • BRZE N/A
  • EPS Growth
  • MRUS N/A
  • BRZE N/A
  • EPS
  • MRUS N/A
  • BRZE N/A
  • Revenue
  • MRUS $54,732,000.00
  • BRZE $620,010,000.00
  • Revenue This Year
  • MRUS $75.57
  • BRZE $20.70
  • Revenue Next Year
  • MRUS $31.84
  • BRZE $16.97
  • P/E Ratio
  • MRUS N/A
  • BRZE N/A
  • Revenue Growth
  • MRUS 42.77
  • BRZE 22.66
  • 52 Week Low
  • MRUS $33.19
  • BRZE $25.22
  • 52 Week High
  • MRUS $62.98
  • BRZE $48.33
  • Technical
  • Relative Strength Index (RSI)
  • MRUS 53.18
  • BRZE 24.75
  • Support Level
  • MRUS $52.41
  • BRZE $26.26
  • Resistance Level
  • MRUS $54.59
  • BRZE $27.28
  • Average True Range (ATR)
  • MRUS 2.15
  • BRZE 1.35
  • MACD
  • MRUS -0.77
  • BRZE -0.82
  • Stochastic Oscillator
  • MRUS 7.62
  • BRZE 4.98

About MRUS Merus N.V.

Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.

About BRZE Braze Inc.

Braze Inc is a customer engagement platform that powers customer-centric interactions between consumers and brands. The company provides solutions for Retail & E-commerce, Media & Entertainment, Financial Services, and Travel & Hospitality related industries. The company offers a single, vertically integrated platform that encompasses the various functionalities, or layers, required for modern customer engagement: data ingestion, classification, orchestration, personalization, and action, all of which is supported by Sage AI by Braze, its AI engine designed to power AI functionality across all layers of this stack. It generates majority of its revenue from the United States.

Share on Social Networks: